P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou, Hecun
P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas. [electronic resource] - Oncology reports Feb 2018 - 501-510 p. digital
Publication Type: Journal Article
1791-2431
10.3892/or.2017.6134 doi
Adult
Antineoplastic Agents--administration & dosage
Brain Neoplasms--drug therapy
Disease Progression
Female
Gene Expression Regulation, Neoplastic
Glioma--drug therapy
Humans
Ki-67 Antigen--genetics
Male
Middle Aged
Mutation
Neoplasm Grading
Procollagen-Proline Dioxygenase--genetics
Prognosis
Protein Disulfide-Isomerases--genetics
Survival Analysis
Treatment Outcome
Tumor Suppressor Protein p53--genetics
Up-Regulation
P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas. [electronic resource] - Oncology reports Feb 2018 - 501-510 p. digital
Publication Type: Journal Article
1791-2431
10.3892/or.2017.6134 doi
Adult
Antineoplastic Agents--administration & dosage
Brain Neoplasms--drug therapy
Disease Progression
Female
Gene Expression Regulation, Neoplastic
Glioma--drug therapy
Humans
Ki-67 Antigen--genetics
Male
Middle Aged
Mutation
Neoplasm Grading
Procollagen-Proline Dioxygenase--genetics
Prognosis
Protein Disulfide-Isomerases--genetics
Survival Analysis
Treatment Outcome
Tumor Suppressor Protein p53--genetics
Up-Regulation